Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial.
about
The path from genome-based research to population health: development of an international public health genomics networkIncidental findings in genetics research using archived DNAExplaining behavior change after genetic testing: the problem of collinearity between test results and risk estimates.The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop.Estimating and disclosing the risk of developing Alzheimer's disease: challenges, controversies and future directionsImplementation and utilization of genetic testing in personalized medicine.Public beliefs and knowledge about risk and protective factors for Alzheimer's diseaseFamilial testicular cancer: interest in genetic testing among high-risk family members.Disclosing individual genetic results to research participants.Informed Choice in Direct-to-Consumer Genetic Testing for Alzheimer and Other Diseases: Lessons from Two CasesInterest in genetic testing for modest changes in breast cancer risk: implications for SNP testing.Associations between self-referral and health behavior responses to genetic risk information.Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions.Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease riskUsing Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomicsGenetic testing for Alzheimer's disease and its impact on insurance purchasing behaviorA randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease.Amyloid imaging, risk disclosure and Alzheimer's disease: ethical and practical issues.Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic CounselorsCommunity engagement about genetic variation research.Education, ethics and knowledge deficits in clinical pharmacogenetics.Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study.Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience.Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease.A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases.Communicating genetic risk information for common disorders in the era of genomic medicine.Disclosure of APOE genotype for risk of Alzheimer's diseaseDistinct communication patterns during genetic counseling for late-onset Alzheimer's risk assessment.Would you want to know? Public attitudes on early diagnostic testing for Alzheimer's disease.Predictors of genetic testing decisions: a systematic review and critique of the literature.The right not to know: the case of psychiatric disorders.Evaluation of a Web-based decision aid for people considering the APOE genetic test for Alzheimer risk.The Influence of Psychosocial and Cognitive Factors on Perceived Threat of Alzheimer's Disease.Genetic susceptibility for Alzheimer's disease: why did adult offspring seek testing?The patterns of inheritance in early-onset dementia: Alzheimer's disease and frontotemporal dementia.HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD).The feasibility of online genetic testing for lung cancer susceptibility: uptake of a web-based protocol and decision outcomes.Overall and domain-specific life satisfaction when living with familial Alzheimer's disease risk: A quantitative approach.A case of inappropriate apolipoprotein e testing in Alzheimer's disease due to lack of an informed consent discussion.Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study.
P2860
Q28252405-012321DC-2B79-47A6-A386-FEBA0838D754Q28283556-5A689E74-DFFC-4506-960D-33CF9FE5F365Q34077824-0AACE2D0-EC45-4538-ACDE-948E67BC290AQ34113976-97AAF426-A457-413F-8A79-1C9944872BB5Q34135724-82BE44A8-07C3-4557-8CD5-CA702FDF91C7Q34147916-BA9F11AD-8188-4124-A2F1-32B3E93123B0Q34177996-60A4CF7C-CD51-4AAD-9975-E22C41D5D37BQ34573358-A3DF86BF-BC66-49DB-9FAF-236778B3F97CQ34579296-F694F1ED-3D42-406F-97EF-5EA2BD511B2AQ34983741-81D9683B-4F6F-4E08-B1E6-39162683CA58Q35016127-27B24410-AB8E-4238-8519-482B61B85CF9Q35030090-0ABF4F9A-3F03-43C1-B07A-EECF01A0AA9DQ35148490-248C0A3D-8B24-47E1-90BB-7529202356E6Q35208130-EB055BEB-ACF0-45FB-B21E-7ADDEB269BA0Q35316963-A7C8C934-9F5C-4F26-9A17-1C6B60F876BBQ35567406-7F81BD67-4C4C-45AA-A983-13C60E1BD1A9Q35706830-50DEC6DD-D423-4124-BEAA-775F532D7A0FQ35838385-E3369B89-636D-42A1-BE47-398A2566B658Q35889850-ACE75E03-06F2-4ED5-AD17-9368B79286E8Q35997424-04E10E38-3ABA-4523-8EA5-D2B0C4789F65Q36745685-67ED8CBE-42D8-4560-B0E3-376173F7FC1BQ36790111-896EB287-64C3-434D-A169-BD689DB9E6ABQ36790121-0EBAE0F9-B9D6-46B5-8D72-329AE0782041Q37031524-BE3CD5A1-644F-4436-9D50-714C1A82FCBAQ37323166-9B2A0B89-EFA5-4302-B876-5DB18F1F7D41Q37389775-01B8076D-5B1A-495B-89D0-89B44BB0ED74Q37423417-0041A77D-51E5-4213-8B3F-CC1F937C97A7Q37590116-337417C9-2870-4413-AD29-35E127D6BA4AQ37690501-C276619B-07BA-4174-BE6D-9D71BDB64EECQ38203489-8CE73A40-DBF2-43B6-86BD-FD8D2A9C1C4AQ38770294-52D62995-07E4-4DE9-A737-3F6B6A44D395Q39217495-92307370-94F9-4CD2-AAE6-27FDCDE7E9A4Q40163132-8529E3E9-5AE1-4759-80D7-E9D0E5107C22Q40359956-FEB46AD8-918F-4412-9EE1-0C798F02BC16Q45103765-808B6B2A-2BCB-43EC-A959-670B06D1EAB3Q45296829-BAB86000-A010-4173-AF13-065722D928AAQ46747840-344DB506-7CDB-4044-B7D1-AFDCA3EAF5BDQ47754247-E46F17F3-E654-4AA2-B283-0B8C5AB406E6Q47905954-1D181B52-09AD-4FFA-B75F-1EB9D4885059Q50747108-32F99573-BBF0-453A-831B-FEAB6658EB85
P2860
Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Who seeks genetic susceptibili ...... te, randomized clinical trial.
@en
type
label
Who seeks genetic susceptibili ...... te, randomized clinical trial.
@en
prefLabel
Who seeks genetic susceptibili ...... te, randomized clinical trial.
@en
P2093
P2860
P50
P1433
P1476
Who seeks genetic susceptibili ...... te, randomized clinical trial.
@en
P2093
A Dessa Sadovnick
J Scott Roberts
Kimberly A Quaid
Lisa D Ravdin
Melissa Barber
Norman R Relkin
Peter J Whitehouse
Stephen G Post
Susan A LaRusse
Tamsen M Brown
P2860
P304
P356
10.1097/01.GIM.0000132688.55591.77
P407
P577
2004-07-01T00:00:00Z
P6179
1001715403